Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02324582
Title MK-3475/BCG in High Risk Superficial Bladder Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Southern Illinois University
Indications

bladder urothelial carcinoma

Therapies

Pembrolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.